POLRMT
protein-codingRNA polymerase mitochondrial, the group of Pentatricopeptide repeat containing
Gene summary
This gene encodes a mitochondrial DNA-directed RNA polymerase. The gene product is responsible for mitochondrial gene expression as well as for providing RNA primers for initiation of replication of the mitochondrial genome. Although this polypeptide has the same function as the three nuclear DNA-directed RNA polymerases, it is more closely related to RNA polymerases of phage and mitochondrial polymerases of lower eukaryotes. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~16.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0859228
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0859228
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0859228
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0859228
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0859228
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0859228
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Musculoskeletal; Neurologic; Renal
Intervention: Biochemical; Renal
Rationale: The condition can involve renal and other manifestations, and medical management for this and other manifestations (eg, with elemental phosphorus, calcitriol, and sodium citrate), has been described as benefiical, including related to musculoskeletal sequelae
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to POLRMT variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_005035.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 42 | 2 | 47 | ||
| missense | 6 | 2 | 367 | 43 | 4 | 422 |
| nonsense | 1 | 6 | 3 | 10 | ||
| start loss | 0 | |||||
| frameshift | 2 | 6 | 1 | 9 | ||
| splice donor/acceptor (+/-2bp) | 2 | 6 | 8 | |||
| Total | 9 | 16 | 380 | 85 | 6 | 496 |
Highest pathogenic variant AF is 0.000699868
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_005026.3 | 21 | MANE Select | |
| Ensembl | ENSP00000465759.2 | 21 | MANE Select | |
| RefSeq | NP_001394734.1 | 21 | Standard | |
| RefSeq | NP_001394735.1 | 21 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Mitochondrial biogenesis
- Mitochondrial Gene Expression
- Gene expression (Transcription)
- Purine metabolism
- Pyrimidine metabolism
Biological Process
- mitochondrial transcription
- transcription initiation from mitochondrial promoter
- mitochondrion organization
Molecular Function
- mitochondrial promoter sequence-specific DNA binding
- RNA binding
- DNA-directed 5'-3' RNA polymerase activity
- protein binding
- sequence-specific DNA binding
Cellular Component
- mitochondrion
- mitochondrial matrix
- protein-containing complex
- mitochondrial DNA-directed RNA polymerase complex
- mitochondrial nucleoid
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000588649
- Coding exons
- 21
- Length
- 16375
- Individuals with no LoFs
- 125625
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 108
- Defined
- 125733
- p
- 0.000430
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -1.87 | 933 | 786 | 1.19 | 0.0000567 | 7758 |
| Missense (PolyPhen) | 301 | 275.09 | 1.0942 | 2690 | ||
| Synonymous | -8.07 | 550 | 356 | 1.54 | 0.0000267 | 2512 |
| Loss of Function | 1.89 | 39 | 54.0 | 0.722 | 0.00000248 | 601 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00045 | 0.00043 | rare |
| Latino/Admixed American | 0.00018 | 0.00017 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00050 | 0.00049 | rare |
| Finnish | 0.00013 | 0.000092 | rare |
| European (Non-Finnish) | 0.00043 | 0.00040 | rare |
| South Asian | 0.0012 | 0.0012 | notable |
| Other | 0.00034 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of mitochondrial DNA into RNA using the four ribonucleoside triphosphates as substrates. {ECO:0000269|PubMed:21278163}.;
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- LoFtool
- 0.770
- RVIS EVS
- -0.02
- RVIS percentile EVS
- 51.92
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- E
- Essential (gene trap)
- K
- Indispensability pred.
- E
- Indispensability score
- 0.847
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |